Ardelyx, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Ardelyx, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-62.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 76% of Healthcare companies in United States.
Cash Locked Ratio
$17For every $100 of sales, $17 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $0 tied up three years earlier.
Less money tied up than 64% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$2Sales grew 681% in 3 years; of every extra $100 of sales, $2 became extra profit.
Lower than 66% of Healthcare companies in United States.
Asset Productivity Ratio
+681% / +164%In 3 years sales changed by +681% while total assets changed by +164%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-28.7×Operating cash was negative last year, while some debt falls due within a year.
Lower than 63% of Healthcare companies in United States.
Cash Cushion Ratio
+7%Cash, after subtracting all debt, equals 7% of its market value (net cash).
Lower than 54% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Ardelyx, Inc. made a loss over the last year. Ardelyx, Inc. owes $0.74 for every $1 it owns. Ardelyx, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossArdelyx, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
5.54The share price is 5.54 times Ardelyx, Inc.'s book value per share, higher than 75% of Healthcare companies in United States.
Market cap
$826 MThe total market value of all of Ardelyx, Inc.'s shares at today's price (share price × number of shares), larger than 61% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$149 MWhat Ardelyx, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.58Net worth divided by the number of shares. The share price of $3.20 is 5.5 times this, which is the P/B above.
Return on equity (ROE)
-38.6%Ardelyx, Inc. lost 38.6% of its shareholders' money over the last year, higher than 56% of Healthcare companies in United States.
Owes vs Owns
0.74×Ardelyx, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Dividend yield
NoneArdelyx, Inc. does not currently pay a dividend.
Revenue growth
+22%Revenue rose 22% in the year to Dec 2025, and grew 98% a year on average over 3 years.
Profit growth
LossArdelyx, Inc. made a loss in each of the last two years.
Profit margin
-15.1%Ardelyx, Inc. lost $15 for every $100 of revenue.
Interest cover
Not coveredArdelyx, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashArdelyx, Inc. held $57 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Ardelyx, Inc.: $826 M ÷ $149 M (30 Jun 2026) = 5.5.
What is Ardelyx, Inc.'s return on equity?
Ardelyx, Inc. lost 38.6% of its shareholders' money over the last year, higher than 56% of Healthcare companies in United States.
How much does Ardelyx, Inc. owe compared with what it owns?
Ardelyx, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Does Ardelyx, Inc. pay a dividend?
No. Ardelyx, Inc. does not currently pay a dividend.
Is Ardelyx, Inc.'s revenue growing?
Revenue rose 22% in the year to Dec 2025, and grew 98% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.